Protein Information

Drug Information

Drug Name Strength Dosage Form/Route Company Marketing Status Approval year
EPERZAN30 MG/0.5 MLPOWDER; SUBCUTANEOUSGLAXOSMITHKLINE INCDiscontinued2017
EPERZAN30 MG/0.5 MLPOWDER; SUBCUTANEOUSGLAXOSMITHKLINE INCDiscontinued2017